Gene · 1616
Papers3,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SENP6 regulates localization and nuclear condensation of DNA damage response proteins by group deSUMOylation. | Nat Commun | 2023 | 37735495 | PubTator, text mining | PubMed |
| The cell-cycle choreography of H3 variants shapes the genome. | Mol Cell | 2023 | 37734377 | PubTator, text mining | PubMed |
| Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions. | MedComm (2020) | 2023 | 37719443 | PubTator, text mining | PubMed |
| Impacts of radiation exposure, hindlimb unloading, and recovery on murine skeletal muscle cell telomere length. | NPJ Microgravity | 2023 | 37714858 | PubTator, text mining | PubMed |
| Independent loss events of a functional tetherin gene in galliform birds. | J Virol | 2023 | 37712707 | PubTator, text mining | PubMed |
| A pan-sarcoma landscape of telomeric content shows that alterations in RAD51B and GID4 are associated with higher telomeric content. | NPJ Genom Med | 2023 | 37709802 | PubTator, text mining | PubMed |
| Liquid‒liquid phase separation: roles and implications in future cancer treatment. | Int J Biol Sci | 2023 | 37705755 | PubTator, text mining | PubMed |
| Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms. | Chin Med J (Engl) | 2023 | 37690992 | PubTator, text mining | PubMed |
| Insight into Tetramolecular DNA G-Quadruplexes Associated with ALS and FTLD: Cation Interactions and Formation of Higher-Ordered Structure. | Int J Mol Sci | 2023 | 37686239 | PubTator, text mining | PubMed |
| An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide. | Diagnostics (Basel) | 2023 | 37685358 | PubTator, text mining | PubMed |
| Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA). | Cancer Cell Int | 2023 | 37679807 | PubTator, text mining | PubMed |
| Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review. | Cancer Rep (Hoboken) | 2023 | 37675821 | PubTator, text mining | PubMed |
| HtrA1 prevents and reverses α-synuclein aggregation, rendering it non-toxic and seeding incompetent. | Res Sq | 2023 | 37674720 | PubTator, text mining | PubMed |
| The emerging roles of SUMOylation in pulmonary diseases. | Mol Med | 2023 | 37670258 | PubTator, text mining | PubMed |
| DAXX safeguards heterochromatin formation in embryonic stem cells. | J Cell Sci | 2023 | 37655670 | PubTator, text mining | PubMed |
| Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma. | Clin Transl Immunology | 2023 | 37649975 | PubTator, text mining | PubMed |
| Clinical significance of genetic profiling based on different anatomic sites in patients with mucosal melanoma who received or did not receive immune checkpoint inhibitors. | Cancer Cell Int | 2023 | 37649078 | PubTator, text mining | PubMed |
| Review on Metal-Based Theranostic Nanoparticles for Cancer Therapy and Imaging. | Technol Cancer Res Treat | 2023 | 37642945 | PubTator, text mining | PubMed |
| HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers. | Nucleic Acids Res | 2023 | 37638746 | PubTator, text mining | PubMed |
| Management Dilemma: Is Enucleation With Lymphadenectomy a Viable Choice for Large Pancreatic Neuroendocrine Tumors (p-NETs)? | Cureus | 2023 | 37637602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1616/papers?page=15